Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
Hua Jiang,He Zhang
DOI: https://doi.org/10.2147/OTT.S364545
IF: 4
2022-05-27
OncoTargets and Therapy
Abstract:Hua Jiang, He Zhang Department of Urology, The Fifth Affiliated Hospital of Zunyi Medical University (Zhuhai Sixth People's Hospital), Zhuhai, People's Republic of China Correspondence: Hua Jiang, The Fifth Affiliated Hospital of Zunyi Medical University (Zhuhai Sixth People's Hospital), No. 1439, Zhufeng Road, Zhuhai, 519100, People's Republic of China, Tel +8613726205880, Email Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentiated neuroendocrine tumor who underwent nephron sparing surgery and no evidence of recurrence or distant metastasis was found during routine follow-up. We searched the case of renal carcinoid with the search phrase "carcinoid [title] and kidney [title]" and "carcinoid [title] and renal [title]" using the PubMed and restricted the search to articles published in English since 2013. The clinical manifestations, age, sex, tumor size, location, gross pathology, light microscopy and immunohistochemistry were analyzed. A total of 28 cases of renal carcinoid were retrieved from PubMed. Higher proportion of positive labeling of CgA, Syn, NSE and CD56 are most valuable in the diagnosis of primary renal well-differentiated neuroendocrine tumor. At present, radical nephrectomy remains the gold standard in the curative-intent therapy for well-differentiated neuroendocrine carcinoma of kidney, in metastatic renal carcinoid, long-term use of octreotide may be an effective adjuvant therapy. Keywords: renal, well-differentiated neuroendocrine tumor, pathological features Carcinoid tumors are low-grade malignant neoplasms which arise from neuroendocrine cells. This type of tumor was mostly located in the digestive tract and respiratory system, and rarely found in the urinary system. Carcinoid tumor of renal is extremely rare. Since the first carcinoid tumor case was reported by Resnick et al 1 in 1966, so far in 2020, there have been around 100 cases reported in the English-language literature. In recent decades, due to wide application of electron microscope, immunohistochemistry, octreotide scintigraphy 2 and positron emission tomography (PET) scan, 3,4 the number of people diagnosed with renal carcinoid has been increasing. However, the incidence rates remained stable all over the world. Here we add one more case of primary renal carcinoid and review the related literature. A 34-year-old woman was found to have a complex renal cyst in her left kidney when she underwent a routine physical examination. The patient denied recent headache, dizziness, flushing, fever, chills, diarrhea, weight loss or night sweats. There was no known history of hypertension, diabetes, cancer, or other relevant family history. The physical examination and biological tests were unremarkable. Enhanced abdominal CT showed a mass of 30 × 40 mm in the upper pole of left renal that was classified as Bosniak category IV (Figure 1). The complete blood count, erythrocyte sedimentation rate, renal and hepatic function tests and serum C-reactive protein of the patient was completely normal. The patient received retroperitoneal laparoscopic nephron sparing surgery (NSS). The macroscopic examination of the surgical specimen revealed a 38×30×30 mm single cyst. Postoperative pathology showed left renal carcinoid tumor (neuroendocrine tumor) (Figure 2). Figure 1 Computed tomographic imaging: The enhanced computed tomographic (CT) scan revealed a mass of 30×40 mm in the upper pole of left renal that was classified as Bosniak category IV. Figure 2 Pathological features of the renal carcinoid: ( A ) H&E (×100) showing nests and cords of neuroendocrine cells, which were arranged in a rosette like structure; ( B ) Positive immunostaining in tumor cells with synaptophysin (×200); ( C ) Intense positive immunostaining for chromogranin in tumor cells (×100); ( D ) Positive immunostaining in tumor cells with CD56 (×200); ( E ) Positive immunostaining in tumor cells with neuron specific enolase (×100). We searched the case of renal carcinoid with the search phrase "carcinoid [title] and kidney [title]" and "carcinoid [title] and renal [title]" using the PubMed and restricted the search to articles published in English. The clinical manifestations, age, sex, tumor size, location, gross pathology, light microscopy and immunohistochemistry of primary renal carcinoid were analyzed. The trial was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent for the publication of this report was obtained from the patie -Abstract Truncated-
oncology,biotechnology & applied microbiology